J1411 Injection, hemgenix, per treatment dose
J-Codes
Also known as: hemgenix, eteplirsen gene therapy
Hemgenix (eteplirsen) injection, per treatment dose. A gene therapy administered by intravenous infusion for hemophilia B treatment.
Clinical Context
Used for hemophilia B (Factor IX deficiency) in patients with severe disease. Gene therapy designed to provide sustained Factor IX production. Single infusion can provide long-term correction of Factor IX deficiency.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.